12 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Management of Fever ... stable and no medical ... #neutropenic #fever ... #IDSA #Algorithm
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Regimen for Multi-Drug ... Build a regimen using ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table ... hematology #warfarin #dosing
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... highlighted circle= clinical ... trial Ever Arias ... Treatment #COVID19 #Pharmacology ... #Table #Management
Cold Urticaria
Prevalence - 0.05% in the population
Disease onset - Mostly 2nd to 4th decades of life
Causes
life Causes and clinical ... Drugs 5. ... symptoms - Headache, fever ... infiltration (lymphocytes ... rheumatology #comparison #table
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... neutropenia < 7 days and clinically ... stable and no medical ... >7 days or • Clinically ... #IDSA #Algorithm
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... disease based on clinical ... please refer to Table ... 5 for dosing recommendation ... infections #HIVAIDS #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... won’t have any clinical ... #Indications #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Clinically Significant ... Cardiovascular Drug-Drug ... Bilberry, Danshen, Dong ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... HIV-infected persons with clinical ... Please refer to the table ... Guidelines for dosing ... infections #HIVAIDS #pharmacology